NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$55,428
-45.7%
3,583
-44.9%
0.00%
Q2 2023$102,146
+80.0%
6,502
+88.8%
0.00%
Q1 2023$56,741
+22.2%
3,443
+15.7%
0.00%
Q4 2022$46,426
+54.8%
2,976
+28.7%
0.00%
Q3 2022$30,000
-11.8%
2,313
-5.1%
0.00%
Q2 2022$34,000
-12.8%
2,438
-10.7%
0.00%
Q1 2022$39,000
+225.0%
2,730
+217.8%
0.00%
Q4 2021$12,000
-87.4%
859
-85.2%
0.00%
Q3 2021$95,000
+578.6%
5,817
+586.8%
0.00%
Q2 2021$14,000
-73.1%
847
-70.1%
0.00%
Q1 2021$52,000
+477.8%
2,836
+494.5%
0.00%
Q4 2020$9,000
-62.5%
477
-64.6%
0.00%
Q3 2020$24,000
+200.0%
1,346
+204.5%
0.00%
Q2 2020$8,000
-71.4%
442
-76.1%
0.00%
Q1 2020$28,000
+115.4%
1,847
+191.3%
0.00%
Q4 2019$13,000
-23.5%
634
-37.0%
0.00%
Q3 2019$17,000
-83.8%
1,007
-83.1%
0.00%
Q2 2019$105,000
-88.4%
5,949
-86.6%
0.00%
-100.0%
Q1 2019$907,00044,5100.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders